Literature DB >> 28322996

Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.

Alexander Junge1, Roza Zandi2, Jakob Hull Havgaard1, Jan Gorodkin3, Jack Bernard Cowland4.   

Abstract

t(8;21) acute myeloid leukemia (AML) is characterized by a translocation between chromosomes 8 and 21 and formation of a distinctive RUNX1-RUNX1T1 fusion transcript. This translocation places RUNX1T1 under control of the RUNX1 promoter leading to a pronounced upregulation of RUNX1T1 transcripts in t(8;21) AML, compared to normal hematopoietic cells. We investigated the role of highly-upregulated RUNX1T1 under the hypothesis that it acts as competing endogenous RNA (ceRNA) titrating microRNAs (miRNAs) away from their target transcripts and thus contributes to AML formation. Using publicly available t(8;21) AML RNA-Seq and miRNA-Seq data available from The Cancer Genome Atlas (TCGA) project, we obtained a network consisting of 605 genes that may act as ceRNAs competing for miRNAs with the suggested RUNX1T1 miRNA sponge. Among the 605 ceRNA candidates, 121 have previously been implied in cancer development. Players in the integrin, cadherin, and Wnt signaling pathways affected by the RUNX1T1 sponge were overrepresented. Finally, among a set of 21 high interest RUNX1T1 ceRNAs we found multiple genes that have previously been linked to AML formation. In conclusion, our study offers a novel look at the role of the RUNX1-RUNX1T1 fusion transcript in t(8;21) AML beyond previously investigated genetic and epigenetic aberrations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Competing endogenous RNAs; RUNX1T1; Regulatory network; miRNA; t(8;21) AML

Mesh:

Substances:

Year:  2017        PMID: 28322996     DOI: 10.1016/j.gene.2017.03.015

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

2.  Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expression.

Authors:  Ko-Hsun Liao; Shing-Jyh Chang; Hsin-Chuan Chang; Chen-Li Chien; Tse-Shun Huang; Te-Chia Feng; Wen-Wei Lin; Chuan-Chi Shih; Muh-Hwa Yang; Shung-Haur Yang; Chi-Hung Lin; Wei-Lun Hwang; Oscar K Lee
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

3.  Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications.

Authors:  Cai Han; Lin-Yu Sun; Wen-Tao Wang; Yu-Meng Sun; Yue-Qin Chen
Journal:  J Mol Cell Biol       Date:  2019-10-25       Impact factor: 6.216

4.  Trdmt1 3'-untranslated region functions as a competing endogenous RNA in leukemia HL-60 cell differentiation.

Authors:  Sha Xu; Jun Xiong; Minjuan Wu; Yu Yang; Junfeng Jiang; Haitao Ni; Yunpeng Zhao; Yue Wang
Journal:  Braz J Med Biol Res       Date:  2020-12-09       Impact factor: 2.590

5.  Circular RNA HECTD1 knockdown inhibits transforming growth factor-beta/ small mothers against decapentaplegic (TGF-β/Smad) signaling to reduce hypertrophic scar fibrosis.

Authors:  Xiaojing Ge; Yute Sun; Youzhi Tang; Jing Lin; Fang Zhou; Gang Yao; Xin Su
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  RUNX oncoproteins and miRNA networks.

Authors:  James C Neil; Jodie Hay; Gillian Borland
Journal:  Oncotarget       Date:  2017-09-07

7.  Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia.

Authors:  Xuejiao Yin; Sui Huang; Ruiqi Zhu; Fengjuan Fan; Chunyan Sun; Yu Hu
Journal:  Cancer Cell Int       Date:  2018-08-28       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.